Log In
Print
BCIQ
Print
Print this Print this
 

THR-184

  Manage Alerts
Collapse Summary General Information
Company Thrasos Therapeutics Inc.
DescriptionCyclic peptide that activates the bone morphogenetic protein (BMP) signaling pathway
Molecular Target Bone morphogenetic protein receptors
Mechanism of ActionBone morphogenetic proteins agonist
Therapeutic ModalityPeptide
Latest Stage of DevelopmentPhase II
Standard IndicationRenal damage
Indication DetailsPrevent acute kidney injury (AKI) in patients undergoing cardiac surgery
Regulatory Designation U.S. - Fast Track (Prevent acute kidney injury (AKI) in patients undergoing cardiac surgery)
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today